# NIR-Guided Sentinel Lymph-Node Mapping for Esophageal Cancer

> **NCT01808417** · PHASE1 · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 10 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** Near Infrared Imaging

## Key facts

- **NCT ID:** NCT01808417
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-21
- **Primary completion:** 2014-04-11
- **Final completion:** 2015-04-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01808417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01808417, "NIR-Guided Sentinel Lymph-Node Mapping for Esophageal Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01808417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*